Cite Filings / FDMT / 0001193125-24-024104

Feed Companies Filings Check

Sign in

S-3ASR

Registration Statement

4D Molecular Therapeutics, Inc. Filed 2024-02-05 Acc 0001193125-24-024104

Documents 1

S-3ASR Registration Statement , d724647ds3asr.htm

Around this filing

2024-02-08 144 Sale of Securities
2024-02-08 424B5 Prospectus
2024-02-07 FWP Free Writing Prospectus
2024-02-07 4 Chief Medical Officer sold 24,552 shares at $30.05 ($737,788)
2024-02-07 3/A 3/A
2024-02-05 424B5 Prospectus
2024-02-05 S-3ASR Registration Statement

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading d724647ds3asr.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…